Techno Trends

Redefining patient treatment through clinically validated software interventions that complement or replace traditional medications, offering personalized, remote, and scalable care for chronic conditions.

Connecting disparate datasets into a unified semantic network to uncover hidden relationships between diseases, drugs, and genetic markers, accelerating discovery and operational decision-making.

Revolutionizing pharmaceutical supply chains through decentralized digital identities that track drug lifecycles from manufacturing to patient delivery, ensuring authenticity and regulatory compliance.

Leveraging mathematically generated datasets to mirror real-world patient populations, enhancing trial efficiency while ensuring absolute privacy and regulatory compliance in modern drug research.

Insilico Medicine has reached a significant clinical milestone with the completion of first-in-human dosing of ISM8969 in a Phase 1 study. Conducted in collaboration with Hygtia Therapeutics, the ISM8969 Phase 1 trial marks the transition of this oral, brain-penetrant...

IQVIA Digital has introduced new technology designed to help pharmaceutical marketers better identify nurse practitioners (NPs) and physician associates (PAs) who prescribe medicines, using insights obtained from POCN Group, the social and professional community for NPs and PAs that...

Sanofi has entered into a multi-year agreement with France-based agentic AI company Owkin to jointly develop next-generation AI-driven biopharma agents. The partnership includes a five-year licence for Owkin's K Pro platform, an advanced AI system designed to augment drug...